Stay updated on Dupilumab in Prurigo Nodularis: Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.

Latest updates to the Dupilumab in Prurigo Nodularis: Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated to v3.4.2 replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check19 days agoChange DetectedAdded a 2026 Am J Clin Dermatol publication entry for dupilumab in prurigo nodularis and updated it to Revision: v3.4.1; removed the previous Online ahead of print entry for the same article (Revision: v3.4.0).SummaryDifference0.1%

- Check34 days agoChange DetectedThe page now displays a Last Update Posted timestamp, and the label 'Last Update Posted (Estimated)' has been removed to clarify update timing. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision: v3.3.4 was released (replacing v3.3.3). There are no substantive changes to the study details or layout.SummaryDifference0.0%

- Check62 days agoChange DetectedThe Study Locations section was expanded to include numerous investigational sites in the US and internationally (Argentina, China, France, Japan, Mexico, Russia, South Korea, and more). This broadens recruitment geography.SummaryDifference2%

- Check91 days agoChange DetectedAdded a note clarifying that publications are automatically filled from PubMed and may not be about the study, and updated the page revision to v3.3.2. The previous PubMed-focused note and revision text (v3.2.0) were removed.SummaryDifference0.1%

Stay in the know with updates to Dupilumab in Prurigo Nodularis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.